Press Releases for CVD

Press Releases
Phase Forward Reports Third Quarter 2009 Results
Covance and Merck & Co., Inc. Finalize Strategic Agreement
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call
Covance Reports Second Quarter Revenue of $466M and EPS of $0.66
Covance to Acquire Seattle-Based Gene Expression Laboratory from Merck & Co., Inc.
Phase Forward Reports Second Quarter 2009 Results
Covance to Sell Its Interactive Voice and Web Response Services and Enter Into a Multi-Year Marketing Agreement with Phase Forward
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2009 Financial Results Conference Call
wRatings and UTEK Corporation's Strategos Identify Most Competitive Health Care Companies
wRatings and UTEK Corporation's Strategos Identify Most Competitive Health Care Companies
Covance to Present at the Drug Information Association's 45th Annual Meeting
Covance to Present at Goldman Sachs Thirtieth Annual Global Healthcare Conference
Covance to Present at William Blair & Company's 29th Annual Growth Stock Conference
Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
Covance to Present at the Deutsche Bank 34th Annual Health Care Conference
Covance To Present at the Bank of America and Merrill Lynch 2009 Health Care Conference
Covance To Present at Baird's 2009 Growth Stock Conference
Covance Elects John McCartney to Company's Board of Directors
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
Covance Opens New Clinical Development Offices in Chile, Peru and Expands Argentina Office
Covance Central Laboratory Receives CAP Accreditation in China
TheFortuneFinancial.Com Initializes Free Analyst Research on SLT, CDR, HP and CVD
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2009 Financial Results Conference Call
Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum
Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
Covance to Present at the Barclays Capital Global Healthcare Conference
Covance Elects Bradley T. Sheares to Company's Board of Directors
Covance to Present at the 2009 UBS Global Healthcare Services Conference
Covance Opens Three New Offices in Ukraine, Slovakia, and Israel
Covance Reports Fourth Quarter and Full-Year 2008 Results
Covance Inc. Invites You to Join the Webcast of Its Fourth Quarter 2008 Financial Results Conference Call
Covance Updates 2008 Financial Targets and Provides 2009 Guidance
Covance Purchases Equity Stake in Caprion Proteomics
Covance Inc. Invites You to Join the Webcast of Its 2009 Guidance Conference Call
Covance to Present at the Credit Suisse 2008 Healthcare Conference
Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2008 Financial Results Conference Call - Oct 23 2008 7:39AM
Covance Reports 3Q08 Earnings of $0.80 Per Share
Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2008 Financial Results Conference Call - Oct 3 2008 12:22PM
Covance Decides to Pursue Its Original Preclinical Strategy in China
Covance To Present at the UBS Global Life Sciences Conference
Covance to Present at the Thomas Weisel Partners Healthcare Conference
Covance and Lilly Enter Into a Strategic R&D Collaboration
Lilly Sells its Greenfield, Indiana, Operations to Covance; Expands Existing Collaboration Between the Two Companies
Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
Covance Recognized for Outstanding Performance by Merck & Co., Inc.
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2008 Financial Results Conference Call - Aug 5 2008 9:19AM
Covance Reports 2Q08 Earnings Growth of 22.7% to $0.79 Per Share
Covance Inc. Invites You to Join the Webcast of Its Second Quarter 2008 Financial Results Conference Call - Jul 1 2008 5:26PM
Covance to Present at the Jefferies 2nd Annual Healthcare Conference
Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
Covance to Present at the William Blair Growth Stock Conference
Covance to Present at the Bank of America 2008 Health Care Conference - Jun 1 2008 5:15PM
Covance to Present at The R.W. Baird 2008 Growth Stock Conference - Jun 1 2008 5:15PM
Covance Elects Joseph C. Scodari to Company's Board of Directors - Jun 1 2008 5:15PM
Covance Reports 1Q08 Earnings Growth of 22.3% to $0.73 Per Share
Covance Inc. Invites You to Join the Webcast of Its First Quarter 2008 Financial Results Conference Call